Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 60
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
Yuanyuan Ma, Xin Li, Jin‐Tai Yu, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 15
The gut microbiota–brain axis in neurological disorders
Mingming You, Nan Chen, Yuanyuan Yang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 7
Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease
Ni Liu, Tianjiao Zhang, Wei Zhao, et al.
Ageing Research Reviews (2025), pp. 102658-102658
Closed Access
Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation
Imanuel Lerman, Yifeng Bu, Rahul Singh, et al.
Bioelectronic Medicine (2025) Vol. 11, Iss. 1
Open Access
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Dissecting the association between gut microbiota and hypertrophic scarring: a bidirectional Mendelian randomization study
Kaikai Xue, Guojian Zhang, Zihao Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3
Implications of Butyrate Signaling Pathways on the Motor Symptomatology of Parkinson’s Disease and Neuroprotective Effects—Therapeutic Approaches: A Systematic Review
Jorge Missiego-Beltrán, Eva María Olalla-Álvarez, Ana González-Brugera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8998-8998
Open Access | Times Cited: 3
Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice
Baoxiang Wang, Lihua Geng, Jing Wang, et al.
Marine Drugs (2024) Vol. 22, Iss. 5, pp. 193-193
Open Access | Times Cited: 1
The influence of aging and the microbiome in multiple sclerosis and other neurologic diseases
Naomi M. Fettig, Annie Pu, Lisa C. Osborne, et al.
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 166-189
Closed Access | Times Cited: 1
Associations Between Different Coffee Types, Neurodegenerative Diseases, and Related Mortality: Findings from a Large Prospective Cohort Study
Tingjing Zhang, Jiangen Song, Zhenfei Shen, et al.
American Journal of Clinical Nutrition (2024) Vol. 120, Iss. 4, pp. 918-926
Closed Access | Times Cited: 1
Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects
Ashutosh Pareek, R. L. Singhal, Aaushi Pareek, et al.
Life Sciences (2024) Vol. 355, pp. 123010-123010
Open Access | Times Cited: 1
The role of gut-derived short-chain fatty acids in Parkinson's disease
Mohamed J. Saadh, Anfal Nabeel Mustafa, Mohammed Ahmed Mustafa, et al.
Neurogenetics (2024) Vol. 25, Iss. 4, pp. 307-336
Closed Access | Times Cited: 1
Microbiome-based therapeutics for Parkinson's disease
Adam M. Hamilton, Ian N Krout, Alexandria C. White, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00462-e00462
Closed Access | Times Cited: 1
Exposure factors and clinical characteristics associated with Parkinson’s disease in GBA1 variant carriers: a Chinese GBA1-PD intrafamilial survey
Xuxiang Zhang, Yuwen Zhao, Li Jiang, et al.
Parkinsonism & Related Disorders (2024) Vol. 130, pp. 107212-107212
Closed Access | Times Cited: 1
Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes
Libo Yu-Taeger, Ali El-Ayoubi, Pengfei Qi, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 469-469
Open Access
Gut microbiota’s role in glioblastoma risk, with a focus on the mediating role of metabolites
Junqing Yan, Bo Li, Chun R. Luo
Frontiers in Neurology (2024) Vol. 15
Open Access
Research Progress on the Relationship between Parkinson's Disease and REM Sleep Behavior Disorder
Yu Zhou, Xiaoli Liu, Bin Xu
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 9
Open Access
A review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory
Wentao Yang, Hua Cui, Chaojie Wang, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Emerging role of gut microbiota extracellular vesicle in neurodegenerative disorders and insights on their therapeutic management
Adil Hassan, Yin Huang, Mahjabina, et al.
iMetaOmics. (2024) Vol. 1, Iss. 2
Open Access
A meta-study of the microbiome and related dysfunction of the brain reveals distinct microbial signatures in the microbiota-gut-brain axis
Yaru Liu, Shitao Li, Tiantian Liu, et al.
Research Square (Research Square) (2024)
Open Access
Microbiome-based therapies for Parkinson’s disease
Mudassir Alam, Kashif Abbas, Mohd Rais Mustafa, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access
Gut microbiota in health and disease: advances and future prospects
Y J Zhang, Hong Wang, Yingpeng Sang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access
Parkinson Hastalığı ve Mikrobiyota
Gözde Dolar, Gülşah Çamcı, Hatice Karabuğa Yakar, et al.
Black Sea Journal of Health Science (2024)
Closed Access
Page 1 - Next Page

Scroll to top